Kirill Gorshkov

National Center for Advancing Translational Sciences

Affiliated withNational Center for Advancing Translational Sciences

Research Area

Biography

Kirill Gorshkov has not added Biography.
If you are Kirill Gorshkov and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2022

Other Publications

Article	Year
Astrocytes as targets for drug discovery. Drug discovery today\| PubMed ID: 29317338	2018
A biosensor for MAPK-dependent Lin28 signaling. Molecular biology of the cell\| PubMed ID: 29540527	2018
Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells. Translational oncology\| PubMed ID: 29982103	2018
Advancing precision medicine with personalized drug screening. Drug discovery today\| PubMed ID: 30125678	2019
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease. Orphanet journal of rare diseases\| PubMed ID: 30220252	2018
Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive Compounds. Translational oncology\| PubMed ID: 30576957	2019
Induced pluripotent stem cells for neural drug discovery. Drug discovery today\| PubMed ID: 30664937	2019
Zika Virus: Origins, Pathological Action, and Treatment Strategies. Frontiers in microbiology\| PubMed ID: 30666246	2018
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of medicinal chemistry\| PubMed ID: 31188588	2019
Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts. Pharmacology research & perspectives\| PubMed ID: 31859463	2019
The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators. bioRxiv : the preprint server for biology\| PubMed ID: 32511355	2020
An OpenData portal to share COVID-19 drug repurposing data in real time. bioRxiv : the preprint server for biology\| PubMed ID: 32511420	2020
Cell-Based No-Wash Fluorescence Assays for Compound Screens Using a Fluorescence Cytometry Plate Reader. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 32532853	2020
RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery. SLAS discovery : advancing life sciences R & D\| PubMed ID: 32660307	2020
Drug Discovery Strategies for SARS-CoV-2. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 32723801	2020
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid. bioRxiv : the preprint server for biology\| PubMed ID: 32839774	2020
Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis. ACS nano\| PubMed ID: 32845122	2020
N-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling. Molecular cancer\| PubMed ID: 33222692	2020
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles. ACS pharmacology & translational science\| PubMed ID: 33330839	2020
Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid. ACS pharmacology & translational science\| PubMed ID: 33330840	2020
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS infectious diseases\| PubMed ID: 33346633	2021
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal transduction and targeted therapy\| PubMed ID: 33361760	2020
Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation. Frontiers in microbiology\| PubMed ID: 33424801	2020
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage. The Journal of biological chemistry\| PubMed ID: 34023384	2021
Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1. Stem cell research\| PubMed ID: 34088014	2021
Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1. Stem cell research\| PubMed ID: 34198154	2021
A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening. bioRxiv : the preprint server for biology\| PubMed ID: 34268508	2021
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry. bioRxiv : the preprint server for biology\| PubMed ID: 34642691	2021
Fluorescent quantum dots enable SARS-CoV-2 antiviral drug discovery and development. Expert opinion on drug discovery\| PubMed ID: 34817309	2022
SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening. ACS pharmacology & translational science\| PubMed ID: 35036857	2022
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry. SLAS discovery : advancing life sciences R & D\| PubMed ID: 35086793	2022
c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease. Frontiers in cell and developmental biology\| PubMed ID: 35399514	2022